ArticleFrontiers in oncology2022

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer.

Huihui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.